Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD Clinical Trial of GM-2505
Gilgamesh Pharmaceuticals, a clinical-stage neuroscience biotech developing best-in-class medicines to redefine mental healthcare, announces the successful completion of its Phase 1 Single Ascending Dose (SAD) trial of GM-2505, a novel 5-HT2A receptor agonist. While initially in development for treatment-resistant depression…
Family Care Center Launches Fourth Austin Clinic in Cedar Park
With the grand opening and ribbon cutting ceremony for its Cedar Park clinic and more clinic openings to follow, Family Care Center continues its commitment to providing mental health care in the Austin metropolitan area. Earlier this year, Mental Health America, ranked Texas last in the nation…
Military Roots Run Deep Through Family Care Center’s Commitment to Breaking the Stigma Around Mental Health
Every year, approximately 200,000 active-duty servicemen and women return to civilian life. Transitions for Veterans can be especially challenging due to shifting from the collective culture of military service to a more individualized role in society. In fact, studies indicate…
